|4Mar 3, 9:31 PM ET

Lavino Francesco Maria 4

4 · Nabriva Therapeutics plc · Filed Mar 3, 2020

Insider Transaction Report

Form 4
Period: 2020-02-28
Lavino Francesco Maria
Chief Commercial Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-02-28$1.35/sh366$494180,464 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4